Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fatty acid oxidation pathway, often referred to as β-oxidation, is a central metabolic process by which fatty acids are broken down in cells to generate energy. This pathway primarily occurs in the mitochondria of eukaryotic cells and involves the sequential removal of two-carbon units from fatty acids, producing acetyl-CoA, NADH, and FADH₂. These products feed into the citric acid cycle (TCA cycle) and electron transport chain for ATP synthesis. Defects in any step can lead to metabolic diseases such as primary carnitine deficiency or medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD). Impaired FAO leads to hypoglycemia during fasting due to insufficient alternative energy production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty Acid Oxidation Pathway (FAO).